Date Posted: April 30, 2026

This billing and coding article has been revised and published for notice under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Effective Date: June 13, 2026

Summary of Changes:

Effective 01/01/2023: Under Excluded CPT/HCPCS Codes, removed asterisk from C9399, J3490, J3590 Risankizumab-rzaa (Skyrizi™) subcutaneous use

Effective 06/13/2026: Under Excluded CPT/HCPCS Codes, added J3490, J3590, C9399 Nemolizumab-ilto (Nemluvio)

Visit the Self-Administered Drugs (SADs) webpage to view the Self-Administered Drug Exclusion List.

To view the complete listing of billing and coding articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Billing and Coding Articles webpage.